Jörg Schwarze, Cologne (Germany)
Dr. Schwarze studied dentistry at the universities of Bologna, Cologne and Bonn, where he completed his doctorate and specialist dental training. Dr. Schwarze has been a certified Invisalign® user in his private practice in Cologne since 2001 and has already treated more than 2000 patients using Invisalign®. He also holds a teaching position at the University of Ferrara (Italy) and publishes regular scientific articles in the field of orthodontics. Dr. Schwarze gives lectures worldwide and is a member of multiple orthodontic associations. He is a founding member of the Clinical Education Council and a member of the European Clinical Advisory Board and Intl. Product Steering Board of Align Technology. He is also general secretary of the German Association for Aligner Orthodontics (DGAO). Since 2006 he has been a consultant at SmileAssist. As a result of his commitment he has already received several national and international awards (German Society for Orthodontics (DGKFO) Award 1992, 2009 and 2013, German Society for Aligner Orthodontics Award 2012, International Research Award of Align Technology 2011, 2012, 2014, 2015 and 2019). Dr. Schwarze is also the developer of the aligner forceps "Gun I", "Gun II" and "Slotmachine", and presented his extraction strategy "IPRpe" ("Smart Extraction") for the first time in 2012. In 2017 he founded the Aligner Academy, a training institute specialized in the aligner therapy. In 2018 he developed the Beneslider forceps "Beneplier A and B" and the "Benepusher".
Interproximal reduction in aligner therapy. A necessary evil or the key to better results?
For a long time, growth control was only possible to a limited extent with aligners. With its MAF (Mandibular Advancement Feature), Align Technology (Invisalign®) has introduced a new treatment option and initiated an interesting approach.
However, neutral studies on this treatment method are few and far between. This study presents the results of 40 patients treated with MAF in private practice.
The clinical and radiological findings are compared with other removable devices for Class II correction, such as activators and Twin Blocks. The results are also compared with other studies.
In this way, fundamental questions will be answered and a better understanding of the biomechanics of the MAF achieved.
Finally there is a critical evaluation of this treatment device in practice, as far as this is possible from what is still very recent experience.